Skip to content

Pharmical

Active
Private limited company· 3 yrs active
Prins Boudewijnlaan 340 ·2610 Antwerpen, Belgium
KBO/BCE: BE 0794.440.886
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age3 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Pharmical is 3.0% (moderate). The 2024 annual accounts show equity of €211k and a net result of €51k. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
3.0% Moderate
0%0,5%1,5%4%10%≥25%
Young company +No NACE activity registered +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 15 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-06-2025, 35 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 2 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 26-06-2025 35 d early 2025-00181046
31-12-2023 31-07-2024 30-08-2024 30 d late 2024-00404512

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€51k
Working capital€-290k+7.8%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 26-06-2025 with the NBB · fiscal year 2024 · verkort
€-50k€-25k€0€25k€50kOperating result 2023: €-23k€-23kNet result 2023: €-40k€-40kOperating result 2024: €10k€10kNet result 2024: €51k€51k20232024
Operating resultNet result
EBITDA
€48k
+519.2% 23-24
Net profit
€51k
- 23-24
Cash flow
€89k
- 23-24
Total assets
€1.58M
+2.2% 23-24
Equity
€211k
+32.0% 23-24
Working capital
€-290k
+7.8% 23-24
Employees (FTE)
0
- 23-24
Debt
€1.37M
-1.2% 23-24
Debt ≤ 1y
€398k
+13.8% 23-24
Debt > 1y
€965k
-6.3% 23-24
Current ratio
0.27
+170.8% 23-24
Quick ratio
0.27
+170.8% 23-24
Solvency
13.4%
+29.1% 23-24
Debt / equity
6.47
-25.2% 23-24
ROE
24.2%
- 23-24
ROA
3.2%
- 23-24
Interest coverage
0.96
+110.1% 23-24
Figures by fiscal year
Fiscal year2024
Depositverkort
Revenue-
EBITDA€48k
Net profit€51k
Cash flow€89k
Staff costs-
Income taxes-
Dividends-
Total assets€1.58M
Equity€211k
Debt€1.37M
of which ≤ 1y€398k
of which > 1y€965k
Working capital€-290k
Employees (FTE)0.0
Ratios (computed)
2024
Current ratio0.27
Quick ratio0.27
Working capital ratio-18.4%
Solvency13.4%
Debt / equity6.47
Long-term debt ratio4.56
Interest coverage0.96
Gross margin-
Net margin-
ROA3.2%
ROE24.2%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€1.58M
Fixed assets 21/28€1.47M
Tangible fixed assets 22/27€315k
Financial fixed assets 28€1.16M
Current assets 29/58€108k
Amounts receivable within one year 40/41€92k
Cash & bank 54/58€16k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.58M
Equity 10/15€211k
Contributions / capital 10/11€200k
Reserves 13€11k
Accumulated profits (losses) 14€0
Amounts payable 17/49€1.37M
Amounts payable after one year 17€965k
Amounts payable within one year 42/48€398k
Trade debts payable within one year 44€588
Income statement
Gross operating margin 9900€50k
Operating result 9901€10k
Financial income 75€92k
Financial charges 65€51k
Result before taxes 9903€51k
Net result for the period 9904€51k
Result to be appropriated 9905€51k
This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
33 / 100 Weak
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap
3 companies at this address See who is registered here

Establishment units

1 location
Pharmical
Prins Boudewijnlaan 340, 2610 AntwerpenHoldings
since 20222.339.340.684
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area609 m²
Buildings1
Building footprint182 m²
Volume (LiDAR)1,469 m³
Tallest building12.1 m · ±3 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11051C0206/00N009 Flanders 609 m² 1 · 182 m² 12.1 m · 3 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Snowflake analysis

financial profile on 5 axes
Health33Profitability100Solvency9Growth78Stability94
63 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 33
Profitability 100
Solvency 9
Growth 78
Stability 94

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Company registry

Company registry (CBE)

Crossroads Bank
Names & trade names
Legal nameNL Pharmical
Registered office
Prins Boudewijnlaan 340
2610 Antwerpen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.